The Gross Margin of Talis Biomedical Corp (TLIS) is 98.08%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 98.08% |
| 2022-12-31 | -74.38% |